2009Chinese Journal of Hospital PharmacyRequires access

Pharmacokinetics of sustained release tablets of actarit in Beagle dogs

Fei Han-yu

Open publisher page 0 citations

Abstract

OBJECTIVE To establish a method for the pharmacokinetics and bioavailability study of atarit in Beagle dogs.METHODS 6 dogs were divided into two groups by double crossing method in two weeks.The concentrations of atarit in plasma were determined by HPLC,and pharmacokinetics parameters were calculated by DAS2.0 program.RESULTS The pharmacokinetics of atarit tablets and atarit sustained release tablets were fitted to one-compartment modle.After dose revised,the results indicated that tmax and t1/2 of atarit sustained release tablets were longer and the Cmax was lower than atarit tablets.The bioavailability of atarit sustained release tablets relative to atarit tablets was(108.9±11.5)%.CONCLUSION Atarit sustained release tablets have marked sustained release characters.

About this research paper

What this paper is about

OBJECTIVE To establish a method for the pharmacokinetics and bioavailability study of atarit in Beagle dogs.METHODS 6 dogs were divided into two groups by double crossing method in two weeks.The concentrations of atarit in plasma were determined by HPLC,and pharmacokinetics parameters were calculated by DAS2.0 program.RESULTS The pharmacokinetics of atarit tablets and atarit sustained release tablets were fitted to one-compartment modle.After dose revised,the results indicated that tmax and t1/2 of atarit sustained release tablets were longer and the Cmax was lower than atarit tablets.The bioavailability of atarit sustained release tablets relative to atarit tablets was(108.9±11.5)%.CONCLUSION Atarit sustained release tablets have marked sustained release characters.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To establish a method for the pharmacokinetics and bioavailability study of atarit in Beagle dogs.METHODS 6 dogs were divided into two groups by double crossing method in two weeks.The concentrations of atarit in plasma were determined by HPLC,and pharmacokinetics parameters were calculated by DAS2.0 program.RESULTS The pharmacokinetics of atarit tablets and atarit sustained release tablets were fitted to one-compartment modle.After dose revised,the results indicated that tmax and t1/2 of atarit sustained release tablets were longer and the Cmax was lower than atarit tablets.The bioavailability of atarit sustained release tablets relative to atarit tablets was(108.9±11.5)%.CONCLUSION Atarit sustained release tablets have marked sustained release characters.

Key concepts: Beagle, Pharmacokinetics, Bioavailability, Cmax, Pharmacology, Plasma concentration, Immediate release, High-performance liquid chromatography

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics of sustained release tablets of actarit in Beagle dogs — Research Paper | ScholarLens